---
title: Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis
date: '2024-10-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39466903/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20241028182403&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: Among patients with asymptomatic severe aortic stenosis,
  a strategy of early TAVR was superior to clinical surveillance in reducing the incidence
  of death, stroke, or unplanned hospitalization for cardiovascular causes. (Funded
  by Edwards Lifesciences; EARLY TAVR ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: Among patients with asymptomatic severe aortic stenosis, a strategy of early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes. (Funded by Edwards Lifesciences; EARLY TAVR ClinicalTrials.gov number, ...